Amino-5-(5-membered)hetero-arylimidazolone compounds and the use thereof for beta-secretase modulation
申请人:Malamas Sotirios Michael
公开号:US20070004786A1
公开(公告)日:2007-01-04
The present invention provides a 2-amino-5-heteroaryl-5-phenylimidazolone compound of formula I
The present invention also provides methods for the use thereof to inhibit β-secretase (BACE) and treat β-amyloid deposits and neurofibrillary tangles
AMINO-5-(6-MEMBERED)HETEROARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR BETA-SECRETASE MODULATION
申请人:Zhou Ping
公开号:US20090042908A1
公开(公告)日:2009-02-12
The present invention provides a 2-amino-5-heteroaryl-5-phenylimidazolone compound of formula I
The present invention also provides methods for the use thereof to inhibit β-secretase (BACE) and treat β-amyloid deposits and neurofibrillary tangles
AMINO-5-(5-MEMBERED)HETERO-ARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR beta-SECRETASE MODULATION
申请人:Malamas Michael Sotirios
公开号:US20080306091A1
公开(公告)日:2008-12-11
The present invention provides a 2-amino-5-heteroaryl-5-phenylimidazolone compound of formula I
The present invention also provides methods for the use thereof to inhibit β-secretase (BACE) and treat β-amyloid deposits and neurofibrillary tangles
Amino-5-(5-membered)hetero-arylimidazolone compounds and the use thereof for β-secretase modulation
申请人:Wyeth
公开号:US07417047B2
公开(公告)日:2008-08-26
The present invention provides a 2-amino-5-heteroaryl-5-phenylimidazolone compound of formula I
The present invention also provides methods for the use thereof to inhibit β-secretase (BACE) and treat β-amyloid deposits and neurofibrillary tangles.
Amino-5-(6-membered)heteroarylimidazolone compounds and the use thereof for β-secretase modulation
申请人:Wyeth
公开号:US07452885B2
公开(公告)日:2008-11-18
The present invention provides a 2-amino-5-heteroaryl-5-phenylimidazolone compound of formula I
The present invention also provides methods for the use thereof to inhibit β-secretase (BACE) and treat β-amyloid deposits and neurofibrillary tangles.